Canine Lymphoma Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: CB7BC550480CEN
Market Monitor Global

Abstracts

Malignant lymphoma or lymphosarcoma are one of the common tumours in canine species such as dogs accounting for approximately 7-24% of all canine tumours and 83% of all canine blood cells malignancies. Canine lymphoma treatment are drugs used in the treatment and mitigation of tumours.

This report contains market size and forecasts of Canine Lymphoma Treatment in Global, including the following market information:

Global Canine Lymphoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Canine Lymphoma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Alkylating Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Canine Lymphoma Treatment include Oasmia Pharmaceutical, VetDC, Aratana Therapeutics, Merck and HylaPharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Canine Lymphoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Canine Lymphoma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Canine Lymphoma Treatment Market Segment Percentages, by Type, 2021 (%)

• Alkylating Agents
• Corticosteroids
• Purine Analogs
• Antimetabolites
• Immune Modulators
• Others

Global Canine Lymphoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Canine Lymphoma Treatment Market Segment Percentages, by Application, 2021 (%)

• Veterinary Hospitals and Clinics
• Ambulatory Care
• Homecare
• Others

Global Canine Lymphoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Canine Lymphoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Canine Lymphoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Canine Lymphoma Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Oasmia Pharmaceutical
• VetDC
• Aratana Therapeutics
• Merck
• HylaPharm

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Canine Lymphoma Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Canine Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANINE LYMPHOMA TREATMENT OVERALL MARKET SIZE

2.1 Global Canine Lymphoma Treatment Market Size: 2021 VS 2028
2.2 Global Canine Lymphoma Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Canine Lymphoma Treatment Players in Global Market
3.2 Top Global Canine Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Canine Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Canine Lymphoma Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Canine Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Canine Lymphoma Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Canine Lymphoma Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Canine Lymphoma Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Canine Lymphoma Treatment Market Size Markets, 2021 & 2028
  4.1.2 Alkylating Agents
  4.1.3 Corticosteroids
  4.1.4 Purine Analogs
  4.1.5 Antimetabolites
  4.1.6 Immune Modulators
  4.1.7 Others
4.2 By Type - Global Canine Lymphoma Treatment Revenue & Forecasts
  4.2.1 By Type - Global Canine Lymphoma Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Canine Lymphoma Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Canine Lymphoma Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Canine Lymphoma Treatment Market Size, 2021 & 2028
  5.1.2 Veterinary Hospitals and Clinics
  5.1.3 Ambulatory Care
  5.1.4 Homecare
  5.1.5 Others
5.2 By Application - Global Canine Lymphoma Treatment Revenue & Forecasts
  5.2.1 By Application - Global Canine Lymphoma Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Canine Lymphoma Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Canine Lymphoma Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Canine Lymphoma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Canine Lymphoma Treatment Revenue & Forecasts
  6.2.1 By Region - Global Canine Lymphoma Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Canine Lymphoma Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Canine Lymphoma Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Canine Lymphoma Treatment Revenue, 2017-2028
  6.3.2 US Canine Lymphoma Treatment Market Size, 2017-2028
  6.3.3 Canada Canine Lymphoma Treatment Market Size, 2017-2028
  6.3.4 Mexico Canine Lymphoma Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Canine Lymphoma Treatment Revenue, 2017-2028
  6.4.2 Germany Canine Lymphoma Treatment Market Size, 2017-2028
  6.4.3 France Canine Lymphoma Treatment Market Size, 2017-2028
  6.4.4 U.K. Canine Lymphoma Treatment Market Size, 2017-2028
  6.4.5 Italy Canine Lymphoma Treatment Market Size, 2017-2028
  6.4.6 Russia Canine Lymphoma Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Canine Lymphoma Treatment Market Size, 2017-2028
  6.4.8 Benelux Canine Lymphoma Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Canine Lymphoma Treatment Revenue, 2017-2028
  6.5.2 China Canine Lymphoma Treatment Market Size, 2017-2028
  6.5.3 Japan Canine Lymphoma Treatment Market Size, 2017-2028
  6.5.4 South Korea Canine Lymphoma Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Canine Lymphoma Treatment Market Size, 2017-2028
  6.5.6 India Canine Lymphoma Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Canine Lymphoma Treatment Revenue, 2017-2028
  6.6.2 Brazil Canine Lymphoma Treatment Market Size, 2017-2028
  6.6.3 Argentina Canine Lymphoma Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Canine Lymphoma Treatment Revenue, 2017-2028
  6.7.2 Turkey Canine Lymphoma Treatment Market Size, 2017-2028
  6.7.3 Israel Canine Lymphoma Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Canine Lymphoma Treatment Market Size, 2017-2028
  6.7.5 UAE Canine Lymphoma Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Oasmia Pharmaceutical
  7.1.1 Oasmia Pharmaceutical Corporate Summary
  7.1.2 Oasmia Pharmaceutical Business Overview
  7.1.3 Oasmia Pharmaceutical Canine Lymphoma Treatment Major Product Offerings
  7.1.4 Oasmia Pharmaceutical Canine Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.1.5 Oasmia Pharmaceutical Key News
7.2 VetDC
  7.2.1 VetDC Corporate Summary
  7.2.2 VetDC Business Overview
  7.2.3 VetDC Canine Lymphoma Treatment Major Product Offerings
  7.2.4 VetDC Canine Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.2.5 VetDC Key News
7.3 Aratana Therapeutics
  7.3.1 Aratana Therapeutics Corporate Summary
  7.3.2 Aratana Therapeutics Business Overview
  7.3.3 Aratana Therapeutics Canine Lymphoma Treatment Major Product Offerings
  7.3.4 Aratana Therapeutics Canine Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.3.5 Aratana Therapeutics Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Canine Lymphoma Treatment Major Product Offerings
  7.4.4 Merck Canine Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 HylaPharm
  7.5.1 HylaPharm Corporate Summary
  7.5.2 HylaPharm Business Overview
  7.5.3 HylaPharm Canine Lymphoma Treatment Major Product Offerings
  7.5.4 HylaPharm Canine Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.5.5 HylaPharm Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Canine Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Canine Lymphoma Treatment Market Drivers in Global Market
Table 3. Canine Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Canine Lymphoma Treatment in Global Market
Table 5. Top Canine Lymphoma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Canine Lymphoma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Canine Lymphoma Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Canine Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Canine Lymphoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Canine Lymphoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Canine Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Canine Lymphoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Canine Lymphoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Canine Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Canine Lymphoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Canine Lymphoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Canine Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Canine Lymphoma Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Canine Lymphoma Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Canine Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Canine Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Canine Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Canine Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Canine Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Oasmia Pharmaceutical Corporate Summary
Table 31. Oasmia Pharmaceutical Canine Lymphoma Treatment Product Offerings
Table 32. Oasmia Pharmaceutical Canine Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 33. VetDC Corporate Summary
Table 34. VetDC Canine Lymphoma Treatment Product Offerings
Table 35. VetDC Canine Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Aratana Therapeutics Corporate Summary
Table 37. Aratana Therapeutics Canine Lymphoma Treatment Product Offerings
Table 38. Aratana Therapeutics Canine Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Canine Lymphoma Treatment Product Offerings
Table 41. Merck Canine Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 42. HylaPharm Corporate Summary
Table 43. HylaPharm Canine Lymphoma Treatment Product Offerings
Table 44. HylaPharm Canine Lymphoma Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Canine Lymphoma Treatment Segment by Type in 2021
Figure 2. Canine Lymphoma Treatment Segment by Application in 2021
Figure 3. Global Canine Lymphoma Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Canine Lymphoma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Canine Lymphoma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Canine Lymphoma Treatment Revenue in 2021
Figure 8. By Type - Global Canine Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Canine Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Canine Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Canine Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 12. US Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Canine Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Canine Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 24. China Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Canine Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Canine Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Canine Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Oasmia Pharmaceutical Canine Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. VetDC Canine Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aratana Therapeutics Canine Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Canine Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. HylaPharm Canine Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)